Following Novartis' suspension of Zelnorm sales and marketing on the United States, the State Food and Drug Administration of China says that it will not force a recall, but instead keep a close watch on the safety of this prescriptive medication.

Original URL: Click here to visit original article
Copyright ChinaCSR.com